nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—CYP1A1—liver cancer	0.311	1	CbGaD
Fluvastatin—UGT2B7—Epirubicin—liver cancer	0.125	0.281	CbGbCtD
Fluvastatin—UGT1A1—Sorafenib—liver cancer	0.0947	0.212	CbGbCtD
Fluvastatin—CYP2B6—Sorafenib—liver cancer	0.0366	0.0822	CbGbCtD
Fluvastatin—CYP3A5—Sorafenib—liver cancer	0.0289	0.0647	CbGbCtD
Fluvastatin—CYP2C8—Sorafenib—liver cancer	0.0278	0.0622	CbGbCtD
Fluvastatin—CYP2C19—Sorafenib—liver cancer	0.0233	0.0522	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—liver cancer	0.0222	0.0498	CbGbCtD
Fluvastatin—CYP1A2—Sorafenib—liver cancer	0.0215	0.0482	CbGbCtD
Fluvastatin—CYP2C9—Sorafenib—liver cancer	0.0194	0.0434	CbGbCtD
Fluvastatin—CYP2D6—Sorafenib—liver cancer	0.0177	0.0397	CbGbCtD
Fluvastatin—CYP3A4—Sorafenib—liver cancer	0.0113	0.0252	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—liver cancer	0.0107	0.0241	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—liver cancer	0.00683	0.0153	CbGbCtD
Fluvastatin—Atorvastatin—AHR—liver cancer	0.0026	0.685	CrCbGaD
Fluvastatin—Rosuvastatin—ALB—liver cancer	0.000638	0.168	CrCbGaD
Fluvastatin—Pitavastatin—ALB—liver cancer	0.000558	0.147	CrCbGaD
Fluvastatin—Angioedema—Sorafenib—liver cancer	0.000461	0.00463	CcSEcCtD
Fluvastatin—Syncope—Sorafenib—liver cancer	0.000452	0.00454	CcSEcCtD
Fluvastatin—Leukopenia—Sorafenib—liver cancer	0.000452	0.00453	CcSEcCtD
Fluvastatin—Jaundice cholestatic—Doxorubicin—liver cancer	0.000449	0.00451	CcSEcCtD
Fluvastatin—Loss of consciousness—Sorafenib—liver cancer	0.000443	0.00445	CcSEcCtD
Fluvastatin—Cough—Sorafenib—liver cancer	0.00044	0.00442	CcSEcCtD
Fluvastatin—Hypertension—Sorafenib—liver cancer	0.000436	0.00437	CcSEcCtD
Fluvastatin—Arthropathy—Doxorubicin—liver cancer	0.000434	0.00436	CcSEcCtD
Fluvastatin—Arthralgia—Sorafenib—liver cancer	0.00043	0.00431	CcSEcCtD
Fluvastatin—Myalgia—Sorafenib—liver cancer	0.00043	0.00431	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000427	0.00428	CcSEcCtD
Fluvastatin—Eructation—Epirubicin—liver cancer	0.000419	0.00421	CcSEcCtD
Fluvastatin—Influenza like illness—Epirubicin—liver cancer	0.000414	0.00416	CcSEcCtD
Fluvastatin—Anaphylactic shock—Sorafenib—liver cancer	0.000412	0.00413	CcSEcCtD
Fluvastatin—Infection—Sorafenib—liver cancer	0.000409	0.00411	CcSEcCtD
Fluvastatin—Shock—Sorafenib—liver cancer	0.000405	0.00407	CcSEcCtD
Fluvastatin—Nervous system disorder—Sorafenib—liver cancer	0.000404	0.00405	CcSEcCtD
Fluvastatin—Thrombocytopenia—Sorafenib—liver cancer	0.000403	0.00405	CcSEcCtD
Fluvastatin—Skin disorder—Sorafenib—liver cancer	0.0004	0.00401	CcSEcCtD
Fluvastatin—Anorexia—Sorafenib—liver cancer	0.000393	0.00394	CcSEcCtD
Fluvastatin—Eructation—Doxorubicin—liver cancer	0.000388	0.00389	CcSEcCtD
Fluvastatin—Influenza like illness—Doxorubicin—liver cancer	0.000383	0.00385	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000375	0.00377	CcSEcCtD
Fluvastatin—Abnormal vision—Epirubicin—liver cancer	0.000372	0.00373	CcSEcCtD
Fluvastatin—Dyspnoea—Sorafenib—liver cancer	0.000367	0.00368	CcSEcCtD
Fluvastatin—Dyspepsia—Sorafenib—liver cancer	0.000362	0.00364	CcSEcCtD
Fluvastatin—Decreased appetite—Sorafenib—liver cancer	0.000358	0.00359	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000356	0.00357	CcSEcCtD
Fluvastatin—Fatigue—Sorafenib—liver cancer	0.000355	0.00356	CcSEcCtD
Fluvastatin—Photosensitivity—Epirubicin—liver cancer	0.000353	0.00354	CcSEcCtD
Fluvastatin—Pain—Sorafenib—liver cancer	0.000352	0.00353	CcSEcCtD
Fluvastatin—Constipation—Sorafenib—liver cancer	0.000352	0.00353	CcSEcCtD
Fluvastatin—Vascular purpura—Epirubicin—liver cancer	0.000346	0.00347	CcSEcCtD
Fluvastatin—Eczema—Epirubicin—liver cancer	0.000345	0.00346	CcSEcCtD
Fluvastatin—Hepatic failure—Epirubicin—liver cancer	0.000345	0.00346	CcSEcCtD
Fluvastatin—Abnormal vision—Doxorubicin—liver cancer	0.000344	0.00345	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Sorafenib—liver cancer	0.000337	0.00338	CcSEcCtD
Fluvastatin—Renal failure acute—Epirubicin—liver cancer	0.000335	0.00337	CcSEcCtD
Fluvastatin—Hot flush—Epirubicin—liver cancer	0.000331	0.00332	CcSEcCtD
Fluvastatin—Menopausal symptoms—Epirubicin—liver cancer	0.000328	0.00329	CcSEcCtD
Fluvastatin—Urticaria—Sorafenib—liver cancer	0.000327	0.00328	CcSEcCtD
Fluvastatin—Photosensitivity—Doxorubicin—liver cancer	0.000326	0.00327	CcSEcCtD
Fluvastatin—Abdominal pain—Sorafenib—liver cancer	0.000326	0.00327	CcSEcCtD
Fluvastatin—Body temperature increased—Sorafenib—liver cancer	0.000326	0.00327	CcSEcCtD
Fluvastatin—Dermatitis bullous—Epirubicin—liver cancer	0.000324	0.00325	CcSEcCtD
Fluvastatin—Purpura—Epirubicin—liver cancer	0.000321	0.00322	CcSEcCtD
Fluvastatin—Vascular purpura—Doxorubicin—liver cancer	0.00032	0.00321	CcSEcCtD
Fluvastatin—Eczema—Doxorubicin—liver cancer	0.000319	0.0032	CcSEcCtD
Fluvastatin—Hepatic failure—Doxorubicin—liver cancer	0.000319	0.0032	CcSEcCtD
Fluvastatin—Renal failure acute—Doxorubicin—liver cancer	0.00031	0.00311	CcSEcCtD
Fluvastatin—Pain in extremity—Epirubicin—liver cancer	0.00031	0.00311	CcSEcCtD
Fluvastatin—Osteoarthritis—Epirubicin—liver cancer	0.00031	0.00311	CcSEcCtD
Fluvastatin—Hot flush—Doxorubicin—liver cancer	0.000306	0.00307	CcSEcCtD
Fluvastatin—Menopausal symptoms—Doxorubicin—liver cancer	0.000304	0.00305	CcSEcCtD
Fluvastatin—Hypersensitivity—Sorafenib—liver cancer	0.000303	0.00304	CcSEcCtD
Fluvastatin—Dermatitis bullous—Doxorubicin—liver cancer	0.0003	0.00301	CcSEcCtD
Fluvastatin—Face oedema—Epirubicin—liver cancer	0.000299	0.003	CcSEcCtD
Fluvastatin—Purpura—Doxorubicin—liver cancer	0.000297	0.00298	CcSEcCtD
Fluvastatin—Asthenia—Sorafenib—liver cancer	0.000295	0.00297	CcSEcCtD
Fluvastatin—Pruritus—Sorafenib—liver cancer	0.000291	0.00292	CcSEcCtD
Fluvastatin—Pain in extremity—Doxorubicin—liver cancer	0.000286	0.00288	CcSEcCtD
Fluvastatin—Osteoarthritis—Doxorubicin—liver cancer	0.000286	0.00288	CcSEcCtD
Fluvastatin—Abdominal pain upper—Epirubicin—liver cancer	0.000283	0.00284	CcSEcCtD
Fluvastatin—Diarrhoea—Sorafenib—liver cancer	0.000282	0.00283	CcSEcCtD
Fluvastatin—Breast disorder—Epirubicin—liver cancer	0.00028	0.00281	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000279	0.0028	CcSEcCtD
Fluvastatin—Nasopharyngitis—Epirubicin—liver cancer	0.000277	0.00278	CcSEcCtD
Fluvastatin—Face oedema—Doxorubicin—liver cancer	0.000277	0.00278	CcSEcCtD
Fluvastatin—Gastritis—Epirubicin—liver cancer	0.000274	0.00275	CcSEcCtD
Fluvastatin—Muscular weakness—Epirubicin—liver cancer	0.000273	0.00274	CcSEcCtD
Fluvastatin—Dizziness—Sorafenib—liver cancer	0.000272	0.00273	CcSEcCtD
Fluvastatin—Influenza—Epirubicin—liver cancer	0.000268	0.00269	CcSEcCtD
Fluvastatin—Eosinophilia—Epirubicin—liver cancer	0.000265	0.00266	CcSEcCtD
Fluvastatin—Pancreatitis—Epirubicin—liver cancer	0.000262	0.00263	CcSEcCtD
Fluvastatin—Vomiting—Sorafenib—liver cancer	0.000262	0.00263	CcSEcCtD
Fluvastatin—Abdominal pain upper—Doxorubicin—liver cancer	0.000262	0.00263	CcSEcCtD
Fluvastatin—Rash—Sorafenib—liver cancer	0.00026	0.00261	CcSEcCtD
Fluvastatin—Dermatitis—Sorafenib—liver cancer	0.000259	0.0026	CcSEcCtD
Fluvastatin—Breast disorder—Doxorubicin—liver cancer	0.000259	0.0026	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000258	0.00259	CcSEcCtD
Fluvastatin—Headache—Sorafenib—liver cancer	0.000258	0.00259	CcSEcCtD
Fluvastatin—Bronchitis—Epirubicin—liver cancer	0.000257	0.00258	CcSEcCtD
Fluvastatin—Nasopharyngitis—Doxorubicin—liver cancer	0.000256	0.00257	CcSEcCtD
Fluvastatin—Gastritis—Doxorubicin—liver cancer	0.000254	0.00254	CcSEcCtD
Fluvastatin—Muscular weakness—Doxorubicin—liver cancer	0.000253	0.00254	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000249	0.0025	CcSEcCtD
Fluvastatin—Influenza—Doxorubicin—liver cancer	0.000248	0.00249	CcSEcCtD
Fluvastatin—Eosinophilia—Doxorubicin—liver cancer	0.000245	0.00246	CcSEcCtD
Fluvastatin—Nausea—Sorafenib—liver cancer	0.000245	0.00245	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Epirubicin—liver cancer	0.000244	0.00245	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—liver cancer	0.000243	0.00244	CcSEcCtD
Fluvastatin—Infestation NOS—Epirubicin—liver cancer	0.000239	0.00239	CcSEcCtD
Fluvastatin—Infestation—Epirubicin—liver cancer	0.000239	0.00239	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—liver cancer	0.000238	0.00239	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000237	0.00237	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Epirubicin—liver cancer	0.000234	0.00235	CcSEcCtD
Fluvastatin—Conjunctivitis—Epirubicin—liver cancer	0.000232	0.00233	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—liver cancer	0.000232	0.00233	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00023	0.00231	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—liver cancer	0.000229	0.0023	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000226	0.00227	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—liver cancer	0.000226	0.00226	CcSEcCtD
Fluvastatin—Sinusitis—Epirubicin—liver cancer	0.000224	0.00225	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—liver cancer	0.000221	0.00222	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—liver cancer	0.000221	0.00222	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000219	0.0022	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000216	0.00217	CcSEcCtD
Fluvastatin—Rhinitis—Epirubicin—liver cancer	0.000215	0.00216	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—liver cancer	0.000215	0.00215	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—liver cancer	0.000215	0.00215	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—liver cancer	0.000214	0.00215	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—liver cancer	0.000213	0.00214	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—liver cancer	0.000213	0.00213	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—liver cancer	0.000212	0.00212	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—liver cancer	0.000211	0.00212	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—liver cancer	0.00021	0.00211	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000209	0.0021	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—liver cancer	0.000207	0.00208	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—liver cancer	0.000206	0.00207	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—liver cancer	0.000203	0.00203	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—liver cancer	0.000199	0.002	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—liver cancer	0.000199	0.002	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—liver cancer	0.000199	0.00199	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—liver cancer	0.000198	0.00199	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—liver cancer	0.000197	0.00198	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—liver cancer	0.000197	0.00197	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—liver cancer	0.000195	0.00196	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—liver cancer	0.000195	0.00195	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—liver cancer	0.000194	0.00195	CcSEcCtD
Fluvastatin—Immune system disorder—Epirubicin—liver cancer	0.000193	0.00194	CcSEcCtD
Fluvastatin—Chills—Epirubicin—liver cancer	0.000192	0.00193	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—liver cancer	0.000191	0.00192	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—liver cancer	0.000191	0.00192	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—liver cancer	0.000189	0.0019	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—liver cancer	0.000188	0.00188	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—liver cancer	0.000187	0.00188	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—liver cancer	0.000186	0.00187	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—liver cancer	0.000184	0.00185	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—liver cancer	0.000184	0.00185	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—liver cancer	0.000184	0.00184	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—liver cancer	0.000183	0.00183	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—liver cancer	0.00018	0.00181	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—liver cancer	0.00018	0.0018	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—liver cancer	0.000179	0.0018	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—liver cancer	0.000179	0.0018	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—liver cancer	0.000178	0.00178	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—liver cancer	0.000177	0.00178	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—liver cancer	0.000175	0.00176	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—liver cancer	0.000174	0.00174	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—liver cancer	0.000173	0.00174	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—liver cancer	0.000173	0.00173	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—liver cancer	0.00017	0.00171	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—liver cancer	0.000169	0.0017	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—liver cancer	0.000168	0.00169	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—liver cancer	0.000168	0.00168	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—liver cancer	0.000167	0.00168	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—liver cancer	0.000167	0.00168	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—liver cancer	0.000167	0.00167	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—liver cancer	0.000166	0.00166	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—liver cancer	0.000164	0.00164	CcSEcCtD
Fluvastatin—Cough—Epirubicin—liver cancer	0.000163	0.00163	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—liver cancer	0.000161	0.00162	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—liver cancer	0.00016	0.00161	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—liver cancer	0.000159	0.00159	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—liver cancer	0.000159	0.00159	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—liver cancer	0.000159	0.00159	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—liver cancer	0.000158	0.00159	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000158	0.00158	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—liver cancer	0.000157	0.00157	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—liver cancer	0.000156	0.00156	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—liver cancer	0.000155	0.00156	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—liver cancer	0.000155	0.00155	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—liver cancer	0.000154	0.00155	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—liver cancer	0.000153	0.00154	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—liver cancer	0.000152	0.00153	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—liver cancer	0.000152	0.00152	CcSEcCtD
Fluvastatin—Infection—Epirubicin—liver cancer	0.000151	0.00152	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—liver cancer	0.000151	0.00151	CcSEcCtD
Fluvastatin—Shock—Epirubicin—liver cancer	0.00015	0.0015	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—liver cancer	0.000149	0.0015	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—liver cancer	0.000149	0.0015	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—liver cancer	0.000149	0.00149	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—liver cancer	0.000148	0.00148	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—liver cancer	0.000147	0.00148	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—liver cancer	0.000147	0.00147	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—liver cancer	0.000147	0.00147	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—liver cancer	0.000147	0.00147	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—liver cancer	0.000146	0.00147	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000146	0.00146	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—liver cancer	0.000145	0.00146	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—liver cancer	0.000145	0.00146	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—liver cancer	0.000142	0.00142	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—liver cancer	0.000141	0.00141	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—liver cancer	0.00014	0.0014	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000139	0.00139	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—liver cancer	0.000139	0.00139	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—liver cancer	0.000138	0.00139	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—liver cancer	0.000138	0.00138	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—liver cancer	0.000138	0.00138	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—liver cancer	0.000137	0.00137	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—liver cancer	0.000137	0.00137	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—liver cancer	0.000136	0.00137	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—liver cancer	0.000136	0.00136	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—liver cancer	0.000134	0.00135	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—liver cancer	0.000134	0.00134	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—liver cancer	0.000132	0.00133	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000131	0.00132	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—liver cancer	0.000131	0.00132	CcSEcCtD
Fluvastatin—Pain—Epirubicin—liver cancer	0.00013	0.00131	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—liver cancer	0.00013	0.00131	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000128	0.00129	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—liver cancer	0.000127	0.00128	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—liver cancer	0.000126	0.00127	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—liver cancer	0.000126	0.00126	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—liver cancer	0.000125	0.00126	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—liver cancer	0.000124	0.00125	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—liver cancer	0.000124	0.00124	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—liver cancer	0.000122	0.00123	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000122	0.00122	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—liver cancer	0.000121	0.00122	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—liver cancer	0.000121	0.00121	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—liver cancer	0.00012	0.00121	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—liver cancer	0.00012	0.00121	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—liver cancer	0.00012	0.00121	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—liver cancer	0.00012	0.00121	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—liver cancer	0.000116	0.00116	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000115	0.00116	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—liver cancer	0.000112	0.00113	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—liver cancer	0.000112	0.00112	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—liver cancer	0.000111	0.00112	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—liver cancer	0.000111	0.00112	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—liver cancer	0.000109	0.0011	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—liver cancer	0.000108	0.00108	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—liver cancer	0.000104	0.00105	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—liver cancer	0.000104	0.00104	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—liver cancer	0.000101	0.00101	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—liver cancer	0.000101	0.00101	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—liver cancer	9.96e-05	0.001	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—liver cancer	9.68e-05	0.000971	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—liver cancer	9.63e-05	0.000967	CcSEcCtD
Fluvastatin—Rash—Epirubicin—liver cancer	9.6e-05	0.000963	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—liver cancer	9.59e-05	0.000962	CcSEcCtD
Fluvastatin—Headache—Epirubicin—liver cancer	9.53e-05	0.000957	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—liver cancer	9.31e-05	0.000935	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—liver cancer	9.04e-05	0.000907	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—liver cancer	8.95e-05	0.000899	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—liver cancer	8.88e-05	0.000891	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—liver cancer	8.87e-05	0.00089	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—liver cancer	8.82e-05	0.000885	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—liver cancer	8.36e-05	0.000839	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—PIK3CB—liver cancer	9.04e-06	6.49e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP2E1—liver cancer	9.01e-06	6.47e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—MTHFR—liver cancer	8.89e-06	6.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GOT2—liver cancer	8.84e-06	6.35e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CD—liver cancer	8.81e-06	6.33e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP2E1—liver cancer	8.8e-06	6.32e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CRABP1—liver cancer	8.78e-06	6.31e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTA4—liver cancer	8.75e-06	6.29e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARA—liver cancer	8.72e-06	6.26e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CRABP1—liver cancer	8.71e-06	6.25e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ALB—liver cancer	8.7e-06	6.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.6e-06	6.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.55e-06	6.14e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTA2—liver cancer	8.53e-06	6.13e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CB—liver cancer	8.52e-06	6.12e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.47e-06	6.08e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYCS—liver cancer	8.43e-06	6.05e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.36e-06	6e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—HPGDS—liver cancer	8.35e-06	6e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PSMA4—liver cancer	8.34e-06	5.99e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PSMD10—liver cancer	8.34e-06	5.99e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP2E1—liver cancer	8.32e-06	5.97e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.3e-06	5.96e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GOT1—liver cancer	8.27e-06	5.94e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GGT1—liver cancer	8.27e-06	5.94e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYCS—liver cancer	8.24e-06	5.91e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTA1—liver cancer	8.23e-06	5.91e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CG—liver cancer	8.15e-06	5.85e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NAT2—liver cancer	8.14e-06	5.84e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GOT2—liver cancer	8.11e-06	5.82e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GGT1—liver cancer	8.08e-06	5.8e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GOT1—liver cancer	8.08e-06	5.8e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.05e-06	5.78e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PPARG—liver cancer	7.86e-06	5.65e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.84e-06	5.63e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.83e-06	5.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.82e-06	5.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALDOB—liver cancer	7.8e-06	5.6e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CPT1B—liver cancer	7.79e-06	5.59e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GLUL—liver cancer	7.79e-06	5.59e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYCS—liver cancer	7.78e-06	5.59e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CB—liver cancer	7.68e-06	5.52e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—HPGDS—liver cancer	7.68e-06	5.51e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GGT1—liver cancer	7.64e-06	5.48e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GOT1—liver cancer	7.64e-06	5.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP2E1—liver cancer	7.62e-06	5.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—HPGDS—liver cancer	7.61e-06	5.47e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.57e-06	5.43e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.56e-06	5.43e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NR1H4—liver cancer	7.51e-06	5.39e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CG—liver cancer	7.47e-06	5.36e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.46e-06	5.36e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CRABP1—liver cancer	7.44e-06	5.34e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PSMD10—liver cancer	7.44e-06	5.34e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PSMA4—liver cancer	7.44e-06	5.34e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTP1—liver cancer	7.43e-06	5.33e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA3—liver cancer	7.39e-06	5.3e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.38e-06	5.3e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—HMOX1—liver cancer	7.32e-06	5.26e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTP1—liver cancer	7.26e-06	5.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GOT2—liver cancer	7.24e-06	5.2e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARG—liver cancer	7.21e-06	5.18e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CD—liver cancer	7.16e-06	5.14e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—HMOX1—liver cancer	7.16e-06	5.14e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYCS—liver cancer	7.13e-06	5.12e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ALB—liver cancer	7.07e-06	5.08e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GGT1—liver cancer	7e-06	5.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GOT1—liver cancer	7e-06	5.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.89e-06	4.95e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTP1—liver cancer	6.86e-06	4.93e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PSMA4—liver cancer	6.84e-06	4.91e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PSMD10—liver cancer	6.84e-06	4.91e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTM1—liver cancer	6.82e-06	4.9e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP2E1—liver cancer	6.81e-06	4.89e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.8e-06	4.89e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PSMD10—liver cancer	6.78e-06	4.87e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PSMA4—liver cancer	6.78e-06	4.87e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—HMOX1—liver cancer	6.76e-06	4.86e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PIK3CA—liver cancer	6.76e-06	4.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA4—liver cancer	6.75e-06	4.85e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.7e-06	4.81e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTM1—liver cancer	6.67e-06	4.79e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GOT2—liver cancer	6.66e-06	4.78e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GOT2—liver cancer	6.6e-06	4.74e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.59e-06	4.73e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA2—liver cancer	6.58e-06	4.73e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CD—liver cancer	6.56e-06	4.71e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HPGDS—liver cancer	6.5e-06	4.67e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ALB—liver cancer	6.48e-06	4.65e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP1A1—liver cancer	6.47e-06	4.65e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.47e-06	4.64e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYCS—liver cancer	6.37e-06	4.57e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA1—liver cancer	6.35e-06	4.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP1A1—liver cancer	6.32e-06	4.54e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTM1—liver cancer	6.3e-06	4.53e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—liver cancer	6.29e-06	4.52e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NAT2—liver cancer	6.28e-06	4.51e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP2E1—liver cancer	6.26e-06	4.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GOT1—liver cancer	6.25e-06	4.49e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GGT1—liver cancer	6.25e-06	4.49e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CB—liver cancer	6.24e-06	4.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP2E1—liver cancer	6.21e-06	4.46e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—HMOX1—liver cancer	6.2e-06	4.45e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—MTHFR—liver cancer	6.03e-06	4.33e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALDOB—liver cancer	6.02e-06	4.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.01e-06	4.31e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARA—liver cancer	5.92e-06	4.25e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—MTHFR—liver cancer	5.9e-06	4.23e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.89e-06	4.23e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYCS—liver cancer	5.86e-06	4.21e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.81e-06	4.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYCS—liver cancer	5.81e-06	4.17e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PSMA4—liver cancer	5.8e-06	4.16e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PSMD10—liver cancer	5.8e-06	4.16e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARA—liver cancer	5.78e-06	4.15e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTM1—liver cancer	5.78e-06	4.15e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GGT1—liver cancer	5.75e-06	4.13e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GOT1—liver cancer	5.75e-06	4.13e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CRABP1—liver cancer	5.74e-06	4.12e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CB—liver cancer	5.72e-06	4.11e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GOT1—liver cancer	5.7e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GGT1—liver cancer	5.7e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GOT2—liver cancer	5.64e-06	4.05e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—liver cancer	5.61e-06	4.03e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—MTHFR—liver cancer	5.57e-06	4e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—HMOX1—liver cancer	5.53e-06	3.97e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—AKT1—liver cancer	5.52e-06	3.96e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PIK3CA—liver cancer	5.51e-06	3.96e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP1A1—liver cancer	5.48e-06	3.93e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARA—liver cancer	5.46e-06	3.92e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP2E1—liver cancer	5.3e-06	3.81e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CA—liver cancer	5.19e-06	3.73e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—liver cancer	5.16e-06	3.71e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTM1—liver cancer	5.16e-06	3.7e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.13e-06	3.69e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—liver cancer	5.12e-06	3.67e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—MTHFR—liver cancer	5.11e-06	3.67e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—HMOX1—liver cancer	5.09e-06	3.66e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CG—liver cancer	5.07e-06	3.64e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—HMOX1—liver cancer	5.05e-06	3.62e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HPGDS—liver cancer	5.02e-06	3.61e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARA—liver cancer	5.01e-06	3.6e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYCS—liver cancer	4.96e-06	3.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CG—liver cancer	4.95e-06	3.56e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.91e-06	3.52e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARG—liver cancer	4.89e-06	3.51e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP1A1—liver cancer	4.89e-06	3.51e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GGT1—liver cancer	4.87e-06	3.5e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GOT1—liver cancer	4.87e-06	3.5e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARG—liver cancer	4.78e-06	3.43e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTM1—liver cancer	4.74e-06	3.41e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTM1—liver cancer	4.7e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CA—liver cancer	4.68e-06	3.36e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CG—liver cancer	4.68e-06	3.36e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—MTHFR—liver cancer	4.56e-06	3.27e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARG—liver cancer	4.52e-06	3.24e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.5e-06	3.23e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—AKT1—liver cancer	4.5e-06	3.23e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP1A1—liver cancer	4.5e-06	3.23e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PSMD10—liver cancer	4.47e-06	3.21e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PSMA4—liver cancer	4.47e-06	3.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARA—liver cancer	4.47e-06	3.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP1A1—liver cancer	4.46e-06	3.2e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CD—liver cancer	4.46e-06	3.2e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ALB—liver cancer	4.4e-06	3.16e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—liver cancer	4.37e-06	3.14e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CD—liver cancer	4.35e-06	3.13e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GOT2—liver cancer	4.35e-06	3.13e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HMOX1—liver cancer	4.31e-06	3.1e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ALB—liver cancer	4.3e-06	3.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CG—liver cancer	4.29e-06	3.08e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—AKT1—liver cancer	4.24e-06	3.05e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—MTHFR—liver cancer	4.19e-06	3.01e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—MTHFR—liver cancer	4.16e-06	2.98e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARG—liver cancer	4.14e-06	2.97e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CD—liver cancer	4.11e-06	2.95e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARA—liver cancer	4.11e-06	2.95e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP2E1—liver cancer	4.09e-06	2.94e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARA—liver cancer	4.08e-06	2.93e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ALB—liver cancer	4.06e-06	2.92e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTM1—liver cancer	4.02e-06	2.89e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.02e-06	2.88e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CB—liver cancer	3.88e-06	2.79e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CG—liver cancer	3.83e-06	2.75e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYCS—liver cancer	3.83e-06	2.75e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—AKT1—liver cancer	3.83e-06	2.75e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP1A1—liver cancer	3.81e-06	2.74e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CA—liver cancer	3.81e-06	2.73e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CB—liver cancer	3.8e-06	2.73e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CD—liver cancer	3.77e-06	2.71e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GGT1—liver cancer	3.76e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GOT1—liver cancer	3.76e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ALB—liver cancer	3.72e-06	2.67e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARG—liver cancer	3.7e-06	2.65e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.66e-06	2.63e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CB—liver cancer	3.59e-06	2.58e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—MTHFR—liver cancer	3.55e-06	2.55e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CG—liver cancer	3.52e-06	2.53e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CG—liver cancer	3.49e-06	2.51e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CA—liver cancer	3.49e-06	2.5e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARA—liver cancer	3.48e-06	2.5e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARG—liver cancer	3.4e-06	2.44e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—liver cancer	3.37e-06	2.42e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARG—liver cancer	3.37e-06	2.42e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CD—liver cancer	3.37e-06	2.42e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HMOX1—liver cancer	3.33e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ALB—liver cancer	3.32e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CB—liver cancer	3.29e-06	2.36e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.13e-06	2.25e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—AKT1—liver cancer	3.11e-06	2.23e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTM1—liver cancer	3.1e-06	2.23e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CD—liver cancer	3.1e-06	2.22e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CD—liver cancer	3.07e-06	2.2e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ALB—liver cancer	3.06e-06	2.2e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ALB—liver cancer	3.03e-06	2.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CG—liver cancer	2.98e-06	2.14e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP1A1—liver cancer	2.94e-06	2.11e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CB—liver cancer	2.93e-06	2.11e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARG—liver cancer	2.88e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—AKT1—liver cancer	2.85e-06	2.05e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—MTHFR—liver cancer	2.74e-06	1.97e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CB—liver cancer	2.7e-06	1.94e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARA—liver cancer	2.69e-06	1.93e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CB—liver cancer	2.68e-06	1.92e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CD—liver cancer	2.62e-06	1.88e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALB—liver cancer	2.59e-06	1.86e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CA—liver cancer	2.37e-06	1.7e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CA—liver cancer	2.31e-06	1.66e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CG—liver cancer	2.3e-06	1.65e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CB—liver cancer	2.29e-06	1.64e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARG—liver cancer	2.22e-06	1.6e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CA—liver cancer	2.19e-06	1.57e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CD—liver cancer	2.02e-06	1.45e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CA—liver cancer	2e-06	1.44e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALB—liver cancer	2e-06	1.44e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—AKT1—liver cancer	1.93e-06	1.39e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—AKT1—liver cancer	1.89e-06	1.36e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CA—liver cancer	1.79e-06	1.28e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—AKT1—liver cancer	1.79e-06	1.28e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CB—liver cancer	1.76e-06	1.27e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CA—liver cancer	1.65e-06	1.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—AKT1—liver cancer	1.64e-06	1.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CA—liver cancer	1.63e-06	1.17e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—AKT1—liver cancer	1.46e-06	1.05e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CA—liver cancer	1.39e-06	1e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—AKT1—liver cancer	1.34e-06	9.65e-06	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—AKT1—liver cancer	1.33e-06	9.57e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—AKT1—liver cancer	1.14e-06	8.18e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CA—liver cancer	1.08e-06	7.73e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKT1—liver cancer	8.79e-07	6.31e-06	CbGpPWpGaD
